EBS stock

Emergent Biosolutions Inc (EBS) revenue is $231.1M

Emergent Biosolutions Inc (EBS) revenue is $231.1M as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.

Read the full EBS research page for quote, filings, and the rest of the model. This satellite exists so “Emergent Biosolutions Inc revenue” can rank with the actual number, then send you to /stock/ebs.

Full EBS analysis